Preparation method of N-sulfinylated sulfonamide derivative

By reacting N-chlorosuccinimide with thiol under an inert atmosphere and coupling N-S with sulfonamide compounds under heating conditions, the problem of using unstable reagents and reaction conditions in traditional methods is solved. It has achieved efficient and environmentally friendly preparation of sulfonamide drugs, suitable for a variety of thiols and sulfonamide compounds, providing a wider range of pharmacological activities and application potential.

CN118978462AInactive Publication Date: 2024-11-19GANNAN MEDICAL UNIV
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411041063.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The preparation method of traditional sulfonamide drugs requires the use of unstable and toxic reagents, the reaction conditions are harsh, and some potentially useful sulfonamide drugs cannot be effectively obtained, and the existing N-S coupling technology is not suitable for sulfonamide compounds.

Method used

By reacting N-chlorosuccinimide with thiol under an inert atmosphere, stable sulfur negative ions are formed and N-S coupled to sulfonamide compounds under heating conditions, the purpose of N-sulfination modification is achieved. , suitable for a variety of thiols and sulfonamide compounds.

Benefits of technology

The preparation of sulfonamide derivatives with high yield, high selectivity, green and environmentally friendly has been achieved, solving the complex catalytic system and environmental pollution problems in traditional methods, and providing a wider range of pharmacological activities and application potential.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004972390140000031
    Figure BDA0004972390140000031
  • Figure BDA0004972390140000051
    Figure BDA0004972390140000051
  • Figure BDA0004972390140000061
    Figure BDA0004972390140000061
Patent Text Reader

Abstract

The invention relates to the technical field of organic synthetic chemistry, in particular to a preparation method of an N-sulfinylated sulfonamide derivative, which comprises the following steps: sequentially adding an organic solvent and N-chlorosuccinimide into mercaptan under the protection of inert gas, mixing for reaction, adding alkali, cooling to room temperature, and filtering to obtain the N-sulfinylated sulfonamide derivative. After the reaction is finished, concentrating under a vacuum condition to obtain a concentrated product; adding sulfanilamide and an organic solvent into the concentrated product, heating for reaction, and then cooling to room temperature to obtain the N-sulfinylated sulfanilamide derivates, mercaptan can directly act on sulfanilamide groups to achieve the purpose of N-S coupling, meanwhile, the preparation method is suitable for various mercaptans and various sulfanilamide compounds, and the preparation method is suitable for industrial production. In addition, the preparation method disclosed by the invention has the characteristics of high target product yield, high selectivity, wide substrate application range, cheap and easily available raw materials, green and environment-friendly reaction process and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of organic synthetic chemistry, and in particular to a method for preparing N-sulfenylated sulfonamide derivatives. Background Art

[0002] Since the discovery of Prontosil, sulfonamides, compounds derived from 4-aminobenzenesulfonamide (sulfonamide), have long been associated with medicine and agriculture due to their broad-spectrum antibacterial activity and inexpensive nature. Traditional structure-activity relationship studies have suggested that the free amino group at the para position of the phenyl group is essential for their antibacterial effects, which can be attributed to the fact that sulfonamides require this substituent to mimic para-aminobenzoic acid (PABA) to inhibit folic acid biosynthesis. With the deepening of research on the structural modification of sulfonamides, it has been found that the introduction of appropriate functional groups on the anilino group of sulfonamide can not only improve its antibacterial properties, but also be expected to produce new pharmacological activities. For example, celecoxib can relieve the signs and symptoms of osteoarthritis and rheumatoid arthritis by inhibiting cyclooxygenase (COX-2); furosemide is a potent diuretic used to treat various edematous diseases. In the past few decades, people have been committed to developing chemical modification methods for the anilino group on the sulfonamide skeleton, and many derivatives with different biological activities have now been obtained, including antifungal, antiparasitic, anticancer, antiepileptic, etc. Among them, molecules modified with sulfur-containing functional groups such as sulfonyl and methylthio have received considerable attention, mainly due to their significant inhibitory effects on various enzymes such as alkaline phosphatase, carbonic anhydrase, and HMG-CoA reductase. However, the traditional preparation methods of these compounds often require the use of unstable and toxic reagents such as sulfonyl chloride or sodium hypochlorite. In addition to the harsh reaction conditions and safety issues, some potentially useful sulfonamide drugs are still not available through the above methods.

[0003] Traditionally, these transformations are based on the condensation reaction of sulfenyl chlorides with amines, or the coupling reaction of disulfides with amines in the presence of transition metals (such as AgNO3, AgOAc, HgCl2, etc.). However, the relatively low reaction efficiency and the requirement for corrosive reagents (such as Cl2, SO2Cl2, etc.) or stoichiometric amounts of noble metals have severely limited the widespread application of classical methods. To overcome these shortcomings, a series of metal-catalyzed SN cross-coupling reactions of amines with thiols, disulfides, and thiosulfonates, or various metal-free direct oxidative coupling systems have been established using iodine, (diacetoxyiodo)benzene (DIB), 2,2,6,6-(tetramethylpiperidin-1-yl)oxy (TEMPO), dibenzyl azodicarboxylate (DBAD), etc. as catalysts or oxidants. In addition, electrochemical synthesis via radical-radical cross-coupling pathways has been demonstrated to be a powerful green and sustainable tool for the construction of compounds containing SN bonds. However, these methods require the involvement of metal catalysts, the addition of highly flammable or irritating oxidants, long reaction times, and the addition of additional additives. Summary of the invention

[0004] In view of the above-mentioned deficiencies in the prior art, the object of the present invention is to provide a method for preparing sulfonamide derivatives of N-sulfenamide, which can achieve the purpose of NS coupling by directly acting on the sulfonaniline group through thiol, and the preparation method of the present invention is applicable to various thiols and various sulfonamide compounds, and selectively N-sulfenylates the aniline groups thereof.

[0005] In order to solve the above technical problems, the present invention adopts the following technical solutions:

[0006] A method for preparing a sulfonamide derivative of N-sulfenamide comprises the following steps:

[0007] Under an inert atmosphere, an organic solvent 1 and N-chlorosuccinimide are sequentially added to the compound of formula III, and the thiol hydrogen of thiophenol is removed by N-chlorosuccinimide to form a stable sulfide anion. The solvent is used to form a homogeneous system and also to better stabilize the sulfide anion. The role of adding a base after the mixed reaction is to remove the byproduct HCl generated by the reaction, and then cooling to room temperature, continuing to stir, and concentrating under vacuum conditions after the reaction is completed to obtain a concentrated product;

[0008] Adding the compound of formula II and organic solvent II to the concentrated product, heating the reaction to achieve the purpose of NS coupling, and then cooling to room temperature to obtain the compound of formula I, i.e., an N-sulfenylated sulfonamide derivative;

[0009]

[0010] R1 can be selected from phenyl, 4-methylbenzene, 4-isopropylbenzene, 4-tert-butylbenzene, 4-methoxybenzene, 4-chlorobenzene, 4-fluorobenzene, 4-bromobenzene, 3-methylbenzene, 3-chlorobenzene, 3-fluorobenzene, 3-bromobenzene, 3-naphthalene, 2-methylbenzene, 2-chlorobenzene, 2-fluorobenzene, 2-bromobenzene, ethyl, isopropyl, tert-butyl, n-butyl, cyclohexyl, thienyl, and R2 can be selected from acetyl, pyridyl, pyrimidinyl with a substituted group, and thiazolyl.

[0011] In a preferred embodiment of the present invention, the compound of formula II is selected from one of sulfonamide, sulfacetamide, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, and sulfadoxine, and the compound of formula III is selected from one of p-methylthiophenol, p-chlorothiophenol, p-tert-butylthiophenol, p-isopropylthiophenol, and p-fluorothiophenol.

[0012] In a preferred embodiment of the present invention, the molar ratio of the compound of formula III to N-chlorosuccinimide is 1:1-2.

[0013] In a preferred embodiment of the present invention, the molar ratio of the organic solvent 1 to the compound of formula III is 25 to 75:1.

[0014] In a preferred embodiment of the present invention, the molar ratio of the compound of formula II to the compound of formula III is 1:1-2, and the volume ratio of the second organic solvent to the first organic solvent is 1:1.5-5.

[0015] In a preferred embodiment of the present invention, the mixed reaction temperature is 0 to 25° C., and the reaction time is 6 to 12 hours.

[0016] In a preferred embodiment of the present invention, the heating reaction temperature is 50-100° C., the reaction time is 12-24 h, and the stirring reaction time is 6-12 h.

[0017] In a preferred embodiment of the present invention, the first organic solvent is one of dichloromethane and toluene, and the second organic solvent is one of dimethyl sulfoxide, ethanol and methanol.

[0018] In a preferred embodiment of the present invention, the base is one of triethylamine, potassium carbonate, sodium hydroxide, sodium bicarbonate, and sodium ethoxide.

[0019] The existing NS coupling technology is not applicable to sulfonamide compounds. At the same time, sulfonamide compounds have two amines in different chemical environments, which have selectivity problems. Sulfonamide compounds are a class of drugs with multiple biological activities. By modifying their structures, there is the potential to obtain new drugs with stronger activities. At the same time, the existing methods for modifying the sulfonamide aniline group mostly form sulfone or sulfoxide structures. The compounds designed by the method of the present invention can form sulfone structures by simple oxidation, which has a wider application value.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] 1. The present invention can directly act on the sulfonaniline group through thiol to achieve the purpose of NS coupling. At the same time, the preparation method of the present invention is applicable to various thiols and various sulfonamide compounds, and selectively N-sulfenylates the aniline groups thereof.

[0022] 2. The S-modified aniline sulfonamide derivatives provided by the present invention and the preparation method thereof have the characteristics of high yield of target products, high selectivity, wide application range of substrates, cheap and easy-to-obtain raw materials, and green and environmentally friendly reaction process. The method solves the problems existing in other synthetic methods, such as complex catalytic systems, large amounts of organic and inorganic wastes, and easy environmental pollution. At the same time, the modified sulfonamide derivatives can continue to undergo other modifications without destroying their original structures, and can be used as precursors of certain compounds with potential therapeutic effects.

[0023] 3. Synthesis process and reaction mechanism of the present invention:

[0024] Synthesis process:

[0025]

[0026] Reaction mechanism:

[0027] The invention comprises the following steps: adding an organic solvent 1 and N-chlorosuccinimide to a compound of formula III under an inert atmosphere, removing the thiol hydrogen of thiophenol by N-chlorosuccinimide to form a stable sulfide anion, adding a base to remove byproducts generated by the reaction after a mixed reaction, cooling to room temperature, and concentrating and removing the solvent under vacuum conditions after the reaction to obtain a concentrated product; adding a compound of formula II and an organic solvent 2 to the concentrated product, heating the product for reaction to achieve the purpose of NS coupling, and then cooling the product to room temperature to obtain an N-sulfenylated sulfonamide derivative.

[0028] DETAILED DESCRIPTION

[0029] The following is a clear and complete description of the technical solutions in the embodiments of the present invention in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] It should be noted that all professional terms used in the present invention are only for the purpose of describing specific embodiments and are not intended to limit the scope of protection of the present invention. Unless otherwise specifically stated, various raw materials, reagents, instruments and equipment used in the following embodiments of the present invention can be purchased from the market or prepared by existing methods.

[0031] Example 1

[0032] The reaction equation is:

[0033]

[0034] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0035] 0.5mmol p-methylthiophenol was added to a 25mL Schlenk reaction tube, and the mixture was vacuumed and backfilled with nitrogen 5 times; under a nitrogen atmosphere, 5mL dichloromethane and 0.5mmol N-chlorosuccinimide were added in sequence, and the mixture was reacted vigorously at 0°C. After 1h, 0.5mmol triethylamine was added, and the mixture was slowly restored to room temperature and stirred vigorously for 12h; after the reaction, the solvent was concentrated and removed under vacuum, and the remaining components were placed in another 25mL Schlenk reaction tube, and 0.5mmol sulfonamide and 3mL ethanol were added in sequence under air conditions, and the mixture was reacted vigorously at 100°C for 12h. After the reaction, the mixture was cooled to room temperature and separated by column chromatography to obtain the target product. The reaction result was 4-((p-tolylthio)amino)benzenesulfonamide with a yield of 92%. 1 H NMR (400MHz, DMSO-d6) δ8.48(s,1H),7.64(d,J=8.7Hz,2H),7.14(d,J=8.1Hz,2H),7.15–7.07(m,6H),2.23(s,3H); 13 CNMR(101MHz,DMSO-d6)δ150.7,136.7,135.2,134.6,129.8,127.5,123.0,113.9,20.6; HRMS(ESI)calcd for C 13 H 14 O2N2S2Na,[M+Na] + :317.0394; found:317.0391.

[0036] Example 2

[0037] The reaction equation is:

[0038]

[0039] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0040] 0.5mmol p-chlorobenzenethiol was added to a 25mL Schlenk reaction tube, and 6mL dichloromethane and 0.75mmol N-chlorosuccinimide were added in turn under air conditions, and the reaction was vigorous at 0°C. After 1h, 0.5mmol potassium carbonate was added, and the temperature was slowly restored to room temperature, and the reaction was continued vigorously for 8h. After the reaction was completed, the solvent was concentrated and removed under vacuum conditions, and the remaining components were placed in another 25mL Schlenk reaction tube. 0.5mmol sulfonamide and 4mL dimethyl sulfoxide were added in turn under air conditions, and the reaction was vigorous at 80°C for 18h. After the reaction was completed, the mixture was cooled to room temperature and separated by column chromatography to obtain the target product. The reaction result was 4-(((4-chlorophenyl)thio)amino)benzenesulfonamide with a yield of 83%. 1 H NMR (400MHz, DMSO-d6) δ8.57(s,1H),7.66(d,J=8.0Hz,2H),7.40(dd,J=6.6Hz,2H),7.18(dd,J=6.7Hz,2H),7.12–7.08(m,4H); 13 C NMR(101MHz,DMSO-d6)δ150.2,139.6,135.0,130.1,129.1,127.5,124.1,113.9; HRMS(ESI)calcd for C 12 H 12 O2ClN2S 2, [M+H] + :315.0029; found:315.0028.

[0041] Example 3

[0042] The reaction equation is:

[0043]

[0044] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0045] 0.75mmol of p-tert-butylthiophenol was added to a 25mL Schlenk reaction tube, and 8mL of toluene and 0.75mmol of N-chlorosuccinimide were added in turn under air conditions, and the reaction was vigorous at 25°C. After 1 hour, 0.75mmol of sodium hydroxide was added, and the temperature was slowly restored to room temperature, and the reaction was continued vigorously for 12 hours. After the reaction was completed, the solvent was concentrated and removed under vacuum conditions, and the remaining components were placed in another 25mL Schlenk reaction tube. 0.5mmol of sulfacetamide and 5mL of dimethyl sulfoxide were added in turn under air conditions, and the reaction was vigorous at 60°C for 20 hours. After the reaction was completed, the reaction was cooled to room temperature and separated by column chromatography to obtain the target product. The reaction result was N-((4-((4-(tert-butyl)phenyl)thio)amino)phenyl)sulfonyl)acetamide, and the yield was 86%. 1 H NMR (400MHz, DMSO-d6) δ11.86(s,1H),8.69(s,1H),7.72(d,J=8.9Hz,2H),7.36(d,J =8.5Hz,2H),7.14(d,J=2.0Hz,2H),7.12(d,J=2.0Hz,2H),1.88(s,3H),1.22(s,9H); 13 C NMR(101MHz,DMSO-d6)δ168.6,152.5,148.7,136.6,129.7,129.0,126.2,122.9,113.8,34.2,31.1,23.3; HRMS(ESI)calcd for C 18 H 23 O3N2S 2, [M+H] + :379.1150; found:379.1152.

[0046] Example 4

[0047] The reaction equation is:

[0048]

[0049] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0050] 1mmol of p-isopropylthiophenol was added to a 25mL Schlenk reaction tube. Under air conditions, 10mL of dichloromethane and 1mmol of N-chlorosuccinimide were added in sequence. The reaction was vigorous at 0°C. After 1h, 1mmol of sodium bicarbonate was added. The mixture was slowly restored to room temperature and continued to react vigorously for 6h. After the reaction was completed, the solvent was concentrated and removed under vacuum conditions. The remaining components were placed in another 25mL Schlenk reaction tube. Under air conditions, 0.5mmol of sulfamethoxazole and 6mL of dimethyl sulfoxide were added in sequence. The mixture was reacted vigorously at 100°C for 12h. After the reaction was completed, the mixture was cooled to room temperature and separated by column chromatography to obtain the target product. The reaction result was 4-(((4-isopropylphenyl)thio)amino)-N-(6-methoxypyrimidin-4-yl)benzenesulfonamide with a yield of 78%. 1 HNMR (400MHz, DMSO-d6) δ11.47(s,1H),8.35(s,1H),7.81(d,J=2.2Hz,1H),7.62(dd,J=8.7,2.3Hz,1H),7.13(d,J=8.3Hz,2H), 6.99(d,J=8.3Hz,2H),6.82(d,J=8.7Hz,1H),6.37(s,2H),6.27(s,1H),3.83(s,3H),2.87–2.76(m,1H),1.15(d,J=6.9Hz,6H); 13 C NMR(101MHz,DMSO-d6)δ169.8,158.8,153.9,146.8,136.6,132.1,129.9,127.7,127.3,114.1,112.5,90.8,54.0,33.0,23.8; HRMS(ESI)calcd for C 20 H 23 O3N4S2,[M+H] + :431.1212; found:431.1226.

[0051] Example 5

[0052] The reaction equation is:

[0053]

[0054] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0055] 1mmol of p-tert-butylthiophenol was added to a 25mL Schlenk reaction tube. Under air conditions, 10mL of toluene and 1mmol of N-chlorosuccinimide were added in sequence. The reaction was vigorous at 0°C. After 1h, 1mmol of sodium ethoxide was added. The temperature was slowly restored to room temperature and the reaction was continued for 6h. After the reaction was completed, the solvent was concentrated and removed under vacuum conditions. The remaining components were placed in another 25mL Schlenk reaction tube. Under air conditions, 0.5mmol of sulfonamide p-methoxypyrimidine and 6mL of ethanol were added in sequence. The reaction was vigorous at 80°C for 18h. After the reaction was completed, the reaction was cooled to room temperature and separated by column chromatography to obtain the target product. The reaction result was 4-(((4-(tert-butyl)phenyl)thio)amino)-N-(5-methoxypyrimidin-2-yl)benzenesulfonamide with a yield of 81%. 1 HNMR(400MHz,DMSO-d6)δ11.24(s,1H),8.57(s,1H),8.26(s,2H),7.80–7. 78(m,2H),7.34–7.31(m,2H),7.11–7.08(m,4H),3.76(s,3H),1.19(s,9H); 13 C NMR(101MHz,DMSO-d6)δ151.8,151.3,149.5,148.6,144.6,136.7,130.5,129.6,126.1,122.9,113.7,56.3,34.2,31.1; HRMS(ESI)calcd.for C 21 H 25 O3N4S2[M+H] + :445.1368; found:445.1394.

[0056] Example 6

[0057] The reaction equation is:

[0058]

[0059] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0060] 1mmol of p-fluorobenzenethiol was added to a 25mL Schlenk reaction tube, and the tube was vacuumed and backfilled with nitrogen 5 times; under a nitrogen atmosphere, 10mL of dichloromethane and 0.5mmol of N-chlorosuccinimide were added in sequence, and the reaction was vigorous at 0°C. After 1h, 1mmol of triethylamine was added, and the reaction was slowly restored to room temperature, and the reaction was continued vigorously for 10h; after the reaction, the solvent was concentrated and removed under vacuum conditions, and the remaining components were placed in another 25mL Schlenk reaction tube, and 0.5mmol of sulfonamide methoxypyridazine and 5mL of dimethyl sulfoxide were added in sequence under air conditions, and the reaction was vigorous at 100°C for 12h. After the reaction was completed, the tube was cooled to room temperature and separated by column chromatography to obtain the target product. The reaction result was 4-(((4-fluorophenyl)thio)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide with a yield of 80%. 1 H NMR(400MHz,DMSO-d6)δ12.65(s,1H),8.57(s,1H),7.66(d,J=8.8Hz,3H),7 .30(d,J=9.8Hz,1H),7.24–7.26(m,4H),7.07(d,J=8.8Hz,2H),3.83(s,3H); 13 C NMR (101MHz, DMSO-d6) δ162.0,159.5,152.7,150.9,135.7(d,J=2.8Hz),132.7,128.2,125.9,125.2,125.1,116.4,116.2,114.1,54.5; 19 F NMR(376MHz,DMSO-d6)δ-117.0; HRMS(ESI)calcd for C 17 H 16 O3FN4S2,[M+H] + :407.0648; found:407.0645.

[0061] Example 7

[0062] The reaction equation is:

[0063]

[0064] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0065] 1mmol of p-fluorobenzenethiol was added to a 25mL Schlenk reaction tube, and the tube was vacuumed and backfilled with nitrogen 5 times; under a nitrogen atmosphere, 10mL of dichloromethane and 0.5mmol of N-chlorosuccinimide were added in sequence, and the reaction was vigorous at 0°C. After 1h, 1mmol of triethylamine was added, and the reaction was slowly restored to room temperature, and the reaction was continued vigorously for 10h; after the reaction, the solvent was concentrated and removed under vacuum conditions, and the remaining components were placed in another 25mL Schlenk reaction tube, and 0.5mmol of sulfadoxine and 3mL of dimethyl sulfoxide were added in sequence under air conditions, and the reaction was vigorous at 60°C for 24h. After the reaction, the tube was cooled to room temperature, and the target product was obtained by column chromatography. The reaction result was 4-(((4-fluorophenyl)thio)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide, and the yield was 90%. 1 H NMR (400MHz, DMSO-d6) δ10.93(s,1H),8.65(s,1H),8.10(s,1H),7.82(d,J=8. 9Hz,2H),7.25–7.18(m,4H),7.09(d,J=9.0Hz,2H),3.89(s,3H),3.66(s,3H); 13 C NMR (101MHz, DMSO-d6) δ162.0,161.5,159.5,151.5,150.7,135.6,135.5,129.6,127.0,125.2,125.1,116.5,116.2,113.7,60.2,54.1; 19 F NMR(376MHz,DMSO-d6)δ-117.0; HRMS(ESI)calcd forC 18 H 18 O4FN4S2,[M+H] + :437.0754; found:437.0761.

[0066] Example 8

[0067] The reaction equation is:

[0068]

[0069] A method for preparing an N-sulfenylated sulfonamide derivative comprises the following steps:

[0070] Add 0.5mmol p-methylthiophenol to a 25mL Schlenk reaction tube, evacuate and backfill with nitrogen 5 times; under a nitrogen atmosphere, add 15mL dichloromethane and 0.5mmol N-chlorosuccinimide in sequence, react vigorously at 12°C, add 0.5mmol triethylamine after 1h, slowly return to room temperature, and continue to stir vigorously for 12h; after the reaction, concentrate and remove the solvent under vacuum, place the remaining components in another 25mL Schlenk reaction tube, add 0.5mmol sulfonamide and 3mL ethanol in sequence under air, react vigorously at 50°C for 24h, cool to room temperature after the reaction, and separate by column chromatography to obtain the target product. The reaction result is 4-((p-tolylthio)amino)benzenesulfonamide.

[0071] The technical features of all the above embodiments can be combined arbitrarily. In order to make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0072] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention should be based on the attached claims, and the description can be used to interpret the content of the claims.

[0073] Obviously, those skilled in the art can make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A method for preparing an N-sulfenylated sulfonamide derivative, characterized in that: The following steps are involved: In an organic solvent 1, a compound of formula III and N-chlorosuccinimide are used as raw materials, and N-chlorosuccinimide is used to remove the thiol hydrogen of thiophenol, so that a stable sulfhydryl anion is formed on the compound of formula III, and under alkaline conditions, the sulfhydryl anion combines with N-chlorosuccinimide to form an intermediate product; In an organic solvent II, the intermediate product and the compound of formula II are used as raw materials to synthesize the compound of formula I, i.e., an N-sulfenylated sulfonamide derivative, through an NS coupling reaction; R1 is selected from one of phenyl, 4-methylbenzene, 4-isopropylbenzene, 4-tert-butylbenzene, 4-methoxybenzene, 4-chlorobenzene, 4-fluorobenzene, 4-bromobenzene, 3-methylbenzene, 3-chlorobenzene, 3-fluorobenzene, 3-bromobenzene, 3-naphthalene, 2-methylbenzene, 2-chlorobenzene, 2-fluorobenzene, 2-bromobenzene, ethyl, isopropyl, tert-butyl, n-butyl, cyclohexyl, and thienyl, and R2 is selected from one of acetyl, pyridyl, pyrimidinyl with a substituted group, and thiazolyl.

2. The method for preparing the N-sulfenylated sulfonamide derivative according to claim 1, characterized in that: The compound of formula II is selected from one of sulfonamide, sulfacetamide, sulfamethoxazole, sulfamethoxazole, sulfamethoxazole, sulfamethoxypyridazine, and sulfadoxine, and the compound of formula III is selected from one of p-methylthiophenol, p-chlorothiophenol, p-tert-butylthiophenol, p-isopropylthiophenol, and p-fluorothiophenol.

3. The method for preparing the N-sulfenylated sulfonamide derivative according to claim 1, characterized in that: The molar ratio of the compound of formula III to N-chlorosuccinimide is 1:1-2.

4. The method for preparing the N-sulfenylated sulfonamide derivative according to claim 1, characterized in that: The molar ratio of the organic solvent 1 to the compound of formula III is 25 to 75:

1.

5. The method for preparing the N-sulfenylated sulfonamide derivative according to claim 1, characterized in that: The molar ratio of the compound of formula II to the compound of formula III is 1:1-2.

6. The method for preparing N-sulfenylated sulfonamide derivatives according to claim 1, characterized in that: The reaction temperature for forming the intermediate product is 0 to 25° C., and the reaction time is 6 to 12 hours.

7. The method for preparing N-sulfenylated sulfonamide derivatives according to claim 1, characterized in that: The reaction temperature of the NS coupling reaction is 50-100°C, and the reaction time is 12-24h.

8. The method for preparing N-sulfenylated sulfonamide derivatives according to claim 1, characterized in that: The first organic solvent is one of dichloromethane and toluene, and the second organic solvent is one of dimethyl sulfoxide, ethanol and methanol.

9. The method for preparing N-sulfenylated sulfonamide derivatives according to claim 1, characterized in that: The volume ratio of the organic solvent 2 to the organic solvent 1 is 1:1.5-5.

10. The method for preparing N-sulfenylated sulfonamide derivatives according to claim 1, characterized in that: The base is one of triethylamine, potassium carbonate, sodium hydroxide, sodium bicarbonate, and sodium ethoxide, and the molar ratio of the base to the compound of formula III is 1:1.

Citation Information

Cited By

  • Synthesis and application of (4-benzyl (p-tolylthio) amino) benzenesulfonamide compound

    CN117964526A

  • Synthesis and Application of (4-Benzyl(p-Tolylthio)amino)benzenesulfonamides

    CN117964526B